BCRX BioCryst Pharmaceuticals Inc

-0.38 (-5.37%)
Last Updated: 14:17:49
Delayed by 15 minutes

Register Free for Streaming Quotes & Tools

Register for Free to get streaming quotes, interactive charts, trades, portfolio, live options flow and more.


Draw Mode:

Volume 1,046,225
Bid Price 6.70
Ask Price 6.71
News -
Day High 7.06


52 Week Range


Day Low 6.69
Company Name Stock Ticker Symbol Market Type
BioCryst Pharmaceuticals Inc BCRX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.38 -5.37% 6.70 14:17:49
Open Price Low Price High Price Close Price Prev Close
7.05 6.69 7.06 7.08
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
10,402 1,046,225 $ 6.88 $ 7,194,618 - 6.62 - 14.50
Last Trade Time Type Quantity Stock Price Currency
14:19:10 1 $ 6.701 USD

BioCryst Pharmaceuticals (BCRX) Options Flow Summary

Overall Flow


Net Premium


Calls / Puts


Buys / Sells




Sweeps Ratio


BioCryst Pharmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
1.27B 189.49M - 270.83M -247.12M -1.30 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

BioCryst Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No BCRX Message Board. Create One! See More Posts on BCRX Message Board See More Message Board Posts

Historical BCRX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week7.307.646.697.332,135,624-0.60-8.22%
1 Month7.167.81996.687.162,604,693-0.46-6.42%
3 Months6.967.956.627.212,565,026-0.26-3.74%
6 Months8.319.0656.627.592,644,202-1.61-19.37%
1 Year12.8614.506.629.322,764,450-6.16-47.9%
3 Years3.4319.993.3610.933,795,2123.2795.34%
5 Years7.3219.991.388.133,773,244-0.62-8.47%

BioCryst Pharmaceuticals Description

BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, with the aim of blocking key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.
Your Recent History
BioCryst P..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now